Enabling Golden-Hour Therapy for Stroke
We’re Changing the Way the World Thinks About Stroke.
The treatment of acute stroke is a race against time that requires swift access to computed tomography or magnetic resonance imaging—luxury diagnostic technology that currently only 10% of the global population can access. Our vision is a future where anybody, anywhere, suspected of a stroke can access life-changing treatments within the golden hour.
Great things come in small packages.
There is more to magnetic resonance than imaging. Axana is a never-seen-before system that harnesses the power of nuclear magnetic resonance for communities least able to access MRI.
The reliance on in-hospital imaging creates massive delays for patients needing urgent diagnoses. With Axana, people suspected of stroke can be diagnosed in the ambulance in real-time.
Axana shares the same underlying principles of nuclear magnetic resonance that power MRI machines around the world. That means Axana gives information that doctors can trust to help make the right decisions.
A fundamental change in approach.
The development of MR technology in medicine has focused on the application of powerful imaging systems. However, the cost of MRI machines has remained unchanged over the past two decades with new systems averaging 1 million per Tesla of magnetic field strength. At such prices, MRIs will remain luxury items with limited global access. At Wellumio, we believe that democratizing MR technology is key to solving long-standing health delivery challenges such as pre-hospital stroke diagnosis.
Revolutionizing stroke care is a team effort. We are empowered by international partners who believe in our mission to solve pre-hospital stroke diagnosis.